Filing Details

Accession Number:
0001437749-24-015399
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-08 16:51:48
Reporting Period:
2024-05-06
Accepted Time:
2024-05-08 16:51:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158895 Lemaitre Vascular Inc LMAT Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365737 W George Lemaitre C/O Lemaitre Vascular, Inc.
63 Second Avenue
Burlington MA 01803
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-05-06 23,206 $76.12 2,179,128 No 4 S Direct
Common Stock Disposition 2024-05-06 29,500 $75.23 2,149,628 No 4 S Direct
Common Stock Disposition 2024-05-06 16,200 $75.94 2,133,428 No 4 S Direct
Common Stock Disposition 2024-05-07 26,044 $75.24 2,107,384 No 4 S Direct
Common Stock Disposition 2024-05-07 20,256 $75.86 2,087,128 No 4 S Direct
Common Stock Disposition 2024-05-08 8,000 $75.30 2,079,128 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Adoption date of referenced 10b5-1(c) plan is: 06-02-2023
  2. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $76.01 to $76.24. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  3. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $74.68 to $75.635. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  4. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $75.6846 to $76.23. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  5. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $74.5584 to $75.5484. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  6. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $75.55 to $76.085. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  7. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $74.9289 to $75.66. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.